18 / 112
16
WFSBP 2015
Scientific Programme Overview
|
Tuesday, 16 June 2015
Trianti
Mitropoulos
Skalkotas
MC 3
MC 2
8:30
S-16
Biological and clinical
aspects of mood dis
orders with psychotic
features
S-17
Recent advances in
understanding and
treating psychiatric
disorders in pregnancy
and postpartum
S-18
Metabotropic glu
tamate receptors
in drug and alcohol
dependence
S-03
Novel mechanisms of
action of antidepres
sant treatment
S-20
Nitric oxide, glutamate
and schizophrenia:
New insights
9:00
9:30
10:00
PL-02
Off label use in
psychiatry
10:30
Break
11:00
D-01
Are children
overmedicated?
S-21
CANMAT clinical
guidelines for bipolar
disorders 2013:
The evolution continues
S-22
Biomarkers in
psychiatric disorders
TG-03
Guidelines on Depres
sion: Globalization or
localization
S-23
Latency to pharmaco
logical treatments in
psychiatric disorders:
Epidemiological,
biological and clinical
aspects
11:30
12:00
12:30
Break
13:00
13:30
SA-03
Industry sponsored
symposium
14:00
14:30
15:00
S-26
Neuroimaging and risk
for schizophrenia
S-27
Therapeutic drug moni
toring, pharmacogene
tics and brain imaging
methods as tools for
improving pharmaco
therapy
TG-04
Task Force on Paraphi
lic Disorders: Paraphilia
treatment for adults
and adolescents
S-28
Glutamatergic mecha
nisms in schizophrenia:
From ketamine to
genetic models
S-29
Alpha4beta2-nicotinic
acetylcholine recep
tors in schizophrenia:
Implications for
smoking cessation and
therapeutics
15:30
16:00
16:30
WS-18
Treating opioid de
pendence: The future
of treatment tailoring
and managing risk for
patients on substitute
opioid therapies
FC-13
Depression
WS-06
Transcranial magnetic
stimulation studies of
neurophysiology, neu
roplasticity, and neuro
cognition in psychiatric
disorders
WS-07
Metabolic disturbances
in schizophrenia: Epi
demiology, pathophy
siology and antipsycho
tics – towards clinical
application of genetic
risk models and new
treatment strategies
WS-08
Pathways associating
stress to the neurobio
logy of suicide
17:00
17:30
18:00
18:30
Hall
Time